Glutathione export during apoptosis requires functional multidrug resistance-associated proteins.
GSH is released in cells undergoing apoptosis, and the present study indicates that the multidrug resistance-associated proteins (MRPs/ABCC) are responsible for this GSH release. Jurkat cells released approximately 75-80% of their total intracellular GSH during both Fas antibody- and staurosporine-induced apoptosis. In contrast, Raji cells, a lymphocyte cell line that is deficient in phosphatidylserine externalization, did not release GSH during apoptosis, and other apoptotic features appeared more slowly in these cells. Jurkat and Raji cell lines expressed comparable MRP and OATP/SLCO (organic anion-transporting polypeptide) mRNA levels, and MRP1 protein levels; however, differences existed in MRP1 localization and function. In Jurkat cells, MRP1 was largely localized to the plasma membrane, and these cells exported the MRP substrate calcein. Calcein release was enhanced during apoptosis. In contrast, Raji cells had little MRP1 at the plasma membrane and did not export calcein under basal or apoptotic conditions, indicating that these cells lack functional MRPs at the plasma membrane. GSH release in Jurkat cells undergoing apoptosis was inhibited by the organic anion transport inhibitors MK571, sulfinpyrazone, and probenecid, supporting a role for the MRP transporters in this process. Furthermore, when MRP1 expression was decreased with RNA interference, GSH release was lower under both basal and apoptotic conditions, providing direct evidence that MRP1 is involved in GSH export.
Hammond
Christine L
CL
Department of Environmental Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA.
Marchan
Rosemarie
R
Krance
Suzanne M
SM
Ballatori
Nazzareno
N
D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism; D001692:Biological Transport; D053148:Caspase 3 / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005978:Glutathione / Q000378:metabolism*; D006801:Humans; D019169:Jurkat Cells; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D027361:Organic Anion Transporters / Q000502:physiology*; D010718:Phosphatidylserines / Q000378:metabolism; D034741:RNA, Small Interfering / Q000494:pharmacology; D019311:Staurosporine / Q000494:pharmacology; D019014:fas Receptor / Q000276:immunology / Q000378:metabolism
D051023:BH3 Interacting Domain Death Agonist Protein; D053148:Caspase 3; D004791:Enzyme Inhibitors; D005978:Glutathione; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D027361:Organic Anion Transporters; D010718:Phosphatidylserines; D034741:RNA, Small Interfering; D019311:Staurosporine; D019014:fas Receptor; C494814:BID protein, human; C491901:FAS protein, human; C421109:multidrug resistance-associated protein 1